Skip to Content

IP 179 (Metformin Hydrochloride Extended Release 750 mg)

Pill with imprint IP 179 is White, Elliptical / Oval and has been identified as Metformin Hydrochloride Extended Release 750 mg. It is supplied by Amneal Pharmaceuticals.

Metformin is used in the treatment of diabetes, type 2; polycystic ovary syndrome; diabetes, type 3c; female infertility; insulin resistance syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IP 179

Metformin hydrochloride extended release 750 mg IP 179
Metformin hydrochloride extended release 750 mg IP 179  Front
Metformin hydrochloride extended release 750 mg IP 179  Back
Metformin hydrochloride extended release 750 mg IP 179
Metformin hydrochloride extended release 750 mg IP 179

Metformin Hydrochloride Extended Release

Imprint:
IP 179
Strength:
750 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Amneal Pharmaceuticals

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0611 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide